title: Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics.
abstract: Oxidative stress, a redox imbalance between the endogenous reactive species and antioxidant systems, is common to numerous pathological conditions such as cancer, central nervous system injuries, radiation injury, diabetes etc. Therefore, compounds able to reduce oxidative stress have been actively sought for over 3 decades. Superoxide is the major species involved in oxidative stress either in its own right or through its progeny, such as ONOO⁻, H₂O₂, •OH, CO₃•⁻, and •NO₂. Hence, the very first compounds developed in the late 1970-ies were the superoxide dismutase (SOD) mimics. Thus far the most potent mimics have been the cationic meso Mn(III) N-substituted pyridylporphyrins and N,N'-disubstituted imidazolylporphyrins (MnPs), some of them with k(cat)(O₂·⁻) similar to the k(cat) of SOD enzymes. Most frequently studied are ortho isomers MnTE-2-PyP⁵⁺, MnTnHex-2-PyP⁵⁺, and MnTDE-2-ImP⁵⁺. The ability to disproportionate O₂·⁻ parallels their ability to remove the other major oxidizing species, peroxynitrite, ONOO⁻. The same structural feature that gives rise to the high k(cat)(O₂·⁻) and k(red)(ONOO⁻), allows MnPs to strongly impact the activation of the redox-sensitive transcription factors, HIF-1α, NF-κB, AP-1, and SP-1, and therefore modify the excessive inflammatory and immune responses. Coupling with cellular reductants and other redox-active endogenous proteins seems to be involved in the actions of Mn porphyrins. While hydrophilic analogues, such as MnTE-2-PyP⁵⁺ and MnTDE-2-ImP⁵⁺ are potent in numerous animal models of diseases, the lipophilic analogues, such as MnTnHex-2-PyP⁵⁺, were developed to cross blood brain barrier and target central nervous system and critical cellular compartments, mitochondria. The modification of its structure, aimed to preserve the SOD-like potency and lipophilicity, and diminish the toxicity, has presently been pursued. The pulmonary radioprotection by MnTnHex-2-PyP⁵⁺ was the first efficacy study performed successfully with non-human primates. The Phase I toxicity clinical trials were done on amyotrophic lateral sclerosis patients with N,N'-diethylimidazolium analogue, MnTDE-2-ImP⁵⁺ (AEOL10150). Its aggressive development as a wide spectrum radioprotector by Aeolus Pharmaceuticals has been supported by USA Federal government. The latest generation of compounds, bearing oxygens in pyridyl substituents is presently under aggressive development for cancer and CNS injuries at Duke University and is supported by Duke Translational Research Institute, The Wallace H. Coulter Translational Partners Grant Program, Preston Robert Tisch Brain Tumor Center at Duke, and National Institute of Allergy and Infectious Diseases. Metal center of cationic MnPs easily accepts and donates electrons as exemplified in the catalysis of O₂·⁻ dismutation. Thus such compounds may be equally good anti- and pro-oxidants; in either case the beneficial therapeutic effects may be observed. Moreover, while the in vivo effects may appear antioxidative, the mechanism of action of MnPs that produced such effects may be pro-oxidative; the most obvious example being the inhibition of NF-κB. The experimental data therefore teach us that we need to distinguish between the mechanism/s of action/s of MnPs and the effects we observe. A number of factors impact the type of action of MnPs leading to favorable therapeutic effects: levels of reactive species and oxygen, levels of endogenous antioxidants (enzymes and low-molecular compounds), levels of MnPs, their site of accumulation, and the mutual encounters of all of those species. The complexity of in vivo redox systems and the complex redox chemistry of MnPs challenge and motivate us to further our understanding of the physiology of the normal and diseased cell with ultimate goal to successfully treat human diseases.
authors: Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA. ibatinic@duke.edu
authors: Ines
authors: I
authors: Batinic-Haberle
authors: Zrinka
authors: Z
authors: Rajic
authors: Artak
authors: A
authors: Tovmasyan
authors: Julio S
authors: JS
authors: Reboucas
authors: Xiaodong
authors: X
authors: Ye
authors: Kam W
authors: KW
authors: Leong
authors: Mark W
authors: MW
authors: Dewhirst
authors: Zeljko
authors: Z
authors: Vujaskovic
authors: Ludmil
authors: L
authors: Benov
authors: Ivan
authors: I
authors: Spasojevic
references: Antioxid Redox Signal. 2004 Jun;6(3):501-12
references: 15130277
references: J Biol Chem. 1969 Nov 25;244(22):6049-55
references: 5389100
references: Asian J Androl. 2009 Nov;11(6):695-702
references: 19802000
references: Radiother Oncol. 2009 Sep;92(3):500-10
references: 19433340
references: Cancer Res. 2010 Jul 15;70(14):5749-58
references: 20570889
references: Free Radic Biol Med. 2005 Apr 1;38(7):839-45
references: 15749379
references: Antioxid Redox Signal. 2009 Mar;11(3):555-70
references: 18754709
references: Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11105-9
references: 18678913
references: Diabetes. 2002 Aug;51(8):2561-7
references: 12145171
references: Expert Opin Investig Drugs. 2006 Nov;15(11):1383-93
references: 17040198
references: Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15215-20
references: 11752464
references: Neurochem Res. 2001 Apr;26(4):337-43
references: 11495343
references: Free Radic Biol Med. 2010 May 1;48(9):1188-96
references: 20138141
references: Antioxid Redox Signal. 2009 Nov;11(11):2651-4
references: 19619007
references: Anticancer Agents Med Chem. 2011 Feb;11(2):181-90
references: 21355846
references: Antioxid Redox Signal. 2010 Jun 1;12(11):1247-69
references: 19764832
references: J Inorg Biochem. 1981 Nov;15(3):261-7
references: 6273505
references: J Inorg Biochem. 2006 Nov;100(11):1897-902
references: 16965820
references: Br J Pharmacol. 2009 Jun;157(4):494-508
references: 19630831
references: Antioxid Redox Signal. 2006 Sep-Oct;8(9-10):1523-32
references: 16987008
references: J Biol Chem. 2003 Feb 28;278(9):6831-7
references: 12475974
references: Free Radic Res. 2007 Feb;41(2):127-34
references: 17364938
references: Free Radic Biol Med. 2004 Jan 15;36(2):233-47
references: 14744635
references: Free Radic Biol Med. 2011 Jul 1;51(1):30-7
references: 21565268
references: Neurosci Lett. 2004 Aug 12;366(2):220-5
references: 15276251
references: Cancer Res. 2010 Mar 1;70(5):1951-9
references: 20160026
references: Curr Eye Res. 2009 Jan;34(1):62-72
references: 19172472
references: Nanomedicine. 2009 Jun;5(2):225-31
references: 19285453
references: Biochim Biophys Acta. 2008 Jul-Aug;1777(7-8):1028-31
references: 18439417
references: Free Radic Biol Med. 2009 Oct 1;47(7):917-23
references: 19631268
references: Anticancer Agents Med Chem. 2011 Feb;11(2):213-21
references: 21395522
references: Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):545-52
references: 16168847
references: Dalton Trans. 2008 Mar 7;(9):1233-42
references: 18283384
references: Anticancer Agents Med Chem. 2011 May 1;11(4):380-4
references: 21453243
references: Free Radic Biol Med. 2009 Jul 1;47(1):72-8
references: 19361553
references: Intensive Care Med. 2004 Dec;30(12):2271-8
references: 15349724
references: Gastroenterology. 2008 Oct;135(4):1344-57
references: 18778711
references: Dalton Trans. 2011 Apr 28;40(16):4111-21
references: 21384047
references: Anticancer Agents Med Chem. 2011 Feb;11(2):233-41
references: 21355847
references: Int J Radiat Biol Relat Stud Phys Chem Med. 1986 Oct;50(4):649-58
references: 3019912
references: Antioxid Redox Signal. 2008 Mar;10(3):511-45
references: 18370854
references: Radiat Res. 2010 Apr;173(4):441-52
references: 20334516
references: J Med Chem. 2009 Dec 10;52(23):7868-72
references: 19954250
references: J Biol Inorg Chem. 2008 Feb;13(2):289-302
references: 18046586
references: Free Radic Biol Med. 2008 Jul 15;45(2):201-10
references: 18457677
references: Free Radic Biol Med. 2002 Aug 1;33(3):379-86
references: 12126760
references: Neurosci Lett. 2009 Nov 27;466(1):41-6
references: 19766169
references: Anticancer Agents Med Chem. 2011 Feb;11(2):178-80
references: 21291402
references: Cancer Biother Radiopharm. 2010 Aug;25(4):439-48
references: 20735206
references: Int J Radiat Biol Relat Stud Phys Chem Med. 1986 Jun;49(6):951-68
references: 3011691
references: Chem Commun (Camb). 2007 Mar 14;(10):1056-8
references: 17325804
references: Neuroscience. 2009 Dec 1;164(2):702-10
references: 19607887
references: J Neurosci. 2001 Jul 1;21(13):4582-92
references: 11425886
references: Anticancer Agents Med Chem. 2011 Feb;11(2):202-12
references: 21291403
references: Anticancer Res. 2009 Jan;29(1):107-18
references: 19331139
references: Diabetes. 2004 Oct;53(10):2559-68
references: 15448084
references: J Cardiovasc Pharmacol. 2003 May;41(5):714-9
references: 12717101
references: Free Radic Res. 2009 Apr;43(4):329-39
references: 19259881
references: Mutagenesis. 2011 May;26(3):431-5
references: 21415439
references: Antioxid Redox Signal. 2011 Aug 15;15(4):1085-127
references: 21275772
references: Ann Neurol. 2005 Aug;58(2):258-65
references: 16049935
references: Free Radic Biol Med. 2009 Aug 1;47(3):250-60
references: 19389472
references: Anticancer Agents Med Chem. 2011 Feb;11(2):222-32
references: 21355841
references: Free Radic Biol Med. 2012 Apr 15;52(8):1272-84
references: 22330065
references: J Biol Chem. 1994 Sep 23;269(38):23471-6
references: 8089112
references: Free Radic Res. 2011 Feb;45(2):188-200
references: 20942564
references: Arch Biochem Biophys. 1997 Jul 15;343(2):225-33
references: 9224734
references: ACS Chem Biol. 2010 Jul 16;5(7):667-80
references: 20524644
references: Diabetes. 2010 Jul;59(7):1731-8
references: 20413509
references: Free Radic Res. 2010 May;44(5):479-96
references: 20370557
references: Antioxid Redox Signal. 2008 Aug;10(8):1343-74
references: 18522489
references: Free Radic Biol Med. 2010 Jun 1;48(11):1501-12
references: 20188820
references: Free Radic Biol Med. 2008 Mar 15;44(6):982-9
references: 18082148
references: Cell Mol Life Sci. 2009 Dec;66(23):3663-73
references: 19629388
references: Nature. 1969 Jun 14;222(5198):1076-8
references: 5787094
references: Am J Respir Crit Care Med. 2003 Jan 1;167(1):57-64
references: 12502477
references: Nat Chem Biol. 2008 May;4(5):278-86
references: 18421291
references: Antioxid Redox Signal. 2009 Oct;11(10):2607-19
references: 19438290
references: Biochem Pharmacol. 2004 Jan 1;67(1):77-85
references: 14667930
references: Curr Med Chem. 2009;16(15):1821-30
references: 19442148
references: J Pharmacol Exp Ther. 2011 Sep;338(3):906-16
references: 21652782
references: N Engl J Med. 1974 Mar 14;290(11):593-7
references: 4359964
references: Free Radic Biol Med. 2002 Oct 1;33(7):947-61
references: 12361805
references: J Mol Cell Cardiol. 2005 Nov;39(5):833-40
references: 16171809
references: Free Radic Biol Med. 2008 Oct 1;45(7):943-9
references: 18598757
references: J Pharm Biomed Anal. 2009 Dec 5;50(5):1088-91
references: 19660888
references: Free Radic Res. 2007 Nov;41(11):1273-82
references: 17957541
references: Dalton Trans. 2010 Dec 28;39(48):11568-76
references: 21052598
references: J Biol Chem. 1998 Sep 18;273(38):24521-8
references: 9733746
references: Cancer Cell. 2004 May;5(5):429-41
references: 15144951
references: Anticancer Agents Med Chem. 2011 Feb;11(2):175-7
references: 21182471
references: J Biol Chem. 2010 Dec 17;285(51):39646-54
references: 20937819
references: Free Radic Biol Med. 2004 Aug 1;37(3):401-10
references: 15223074
references: Cancer Res. 2005 Feb 15;65(4):1401-5
references: 15735027
references: Neurobiol Dis. 2007 Apr;26(1):1-13
references: 17300945
references: Diabetes. 2002 Feb;51(2):347-55
references: 11812741
references: Radiat Res. 2010 Jun;173(6):748-59
references: 20518654
references: Dalton Trans. 2004 Jun 7;(11):1696-702
references: 15252564
references: Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):573-80
references: 17236973
references: Free Radic Biol Med. 2006 Sep 15;41(6):937-41
references: 16934676
references: Curr Opin Immunol. 2004 Feb;16(1):42-7
references: 14734109
references: Free Radic Biol Med. 2009 Oct 1;47(7):992-1004
references: 19591920
references: Neuroscience. 2008 Apr 22;153(1):120-30
references: 18353561
references: Arch Biochem Biophys. 1997 Nov 15;347(2):271-4
references: 9367535
references: J Biol Chem. 2003 Jul 25;278(30):27432-8
references: 12700236
references: Int J Radiat Biol. 2010 Feb;86(2):145-63
references: 20148700
references: Mol Interv. 2010 Feb;10(1):39-50
references: 20124562
references: Anticancer Agents Med Chem. 2011 May 1;11(4):341-6
references: 21453242
references: Curr Opin Investig Drugs. 2006 Jan;7(1):70-80
references: 16425674
references: Free Radic Biol Med. 2010 Apr 15;48(8):1034-43
references: 20096348
references: Free Radic Biol Med. 2010 Jul 15;49(2):130-43
references: 20353819
references: Redox Rep. 2009;14(6):236-42
references: 20003708
references: J Pharm Biomed Anal. 2008 Nov 4;48(3):1046-9
references: 18804338
references: Mech Ageing Dev. 2008 Jun;129(6):322-31
references: 18400258
references: Anticancer Agents Med Chem. 2011 May 1;11(4):329-40
references: 21355843
references: Free Radic Biol Med. 2009 Jan 15;46(2):212-9
references: 18983908
references: Amino Acids. 2012 Jan;42(1):95-113
references: 20473774
references: Inorg Chem. 2002 Nov 4;41(22):5874-81
references: 12401096
references: Free Radic Biol Med. 2009 Jan 15;46(2):192-201
references: 19007878
references: Free Radic Biol Med. 2007 Apr 15;42(8):1193-200
references: 17382200
references: Free Radic Biol Med. 2004 Jul 15;37(2):272-83
references: 15203198
references: Free Radic Biol Med. 2010 Nov 1;49(8):1298-305
references: 20673847
references: J Inorg Biochem. 1979 Nov;11(3):261-7
references: 229199
references: Free Radic Biol Med. 2004 Aug 1;37(3):367-74
references: 15223070
references: J Clin Invest. 1973 Mar;52(3):741-4
references: 4346473
references: Free Radic Res. 2010 Jul;44(7):773-82
references: 20380592
references: Antioxid Redox Signal. 2010 Aug 15;13(4):467-87
references: 20001746
references: Annu Rev Pharmacol Toxicol. 2007;47:629-56
references: 17014364
references: Int J Toxicol. 2010 Jul;29(4 Suppl):151S-61S
references: 20634505
references: Antioxid Redox Signal. 2010 Sep 15;13(6):877-918
references: 20095865
references: Free Radic Biol Med. 2006 Aug 1;41(3):503-12
references: 16843831
references: Cancer Res. 2009 Jul 1;69(13):5450-7
references: 19549914
references: Immunol Res. 2002;26(1-3):95-105
references: 12403349
references: J Biol Chem. 1996 Aug 30;271(35):21037-40
references: 8702868
references: J Biol Chem. 1999 Feb 12;274(7):4202-6
references: 9933617
references: Int J Radiat Biol Relat Stud Phys Chem Med. 1982 Oct;42(4):449-56
references: 6293987
references: Anticancer Agents Med Chem. 2011 Feb;11(2):191-201
references: 21434856
references: Free Radic Biol Med. 2007 May 15;42(10):1571-8
references: 17448904